Understanding Stem Cell Therapy in Parkinson’s Disease Treatment

On April 29, 2018, the Washington Post published an article

examining commercial stem cell clinics in the United States that market non-FDA approved treatments directly to the public for a variety of health issues, including arthritis, macular degeneration and of particular note to us, Parkinson’s disease (PD).

Pictured: Dopamine neurons derived from iPSCs from the lab of Xiaobo Mao, Phd

Read More